May 2006
Volume 47, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2006
Evaluation of Clinical Tolerance to Soft Contact Lens (SCL) Care Systems
Author Affiliations & Notes
  • G. Fuentes–Paez
    IOBA, University of Valladolid, Valladolid, Spain
  • M.J. Gonzalez–Garcia
    IOBA, University of Valladolid, Valladolid, Spain
  • A. Gonzalez–Saiz
    IOBA, University of Valladolid, Valladolid, Spain
  • A. Morilla–Grasa
    IOBA, University of Valladolid, Valladolid, Spain
  • A. Enriquez de Salamanca
    IOBA, University of Valladolid, Valladolid, Spain
  • C. Garcia–Vazquez
    IOBA, University of Valladolid, Valladolid, Spain
  • J.M. Herreras
    IOBA, University of Valladolid, Valladolid, Spain
  • M. Calonge
    IOBA, University of Valladolid, Valladolid, Spain
  • Footnotes
    Commercial Relationships  G. Fuentes–Paez, None; M.J. Gonzalez–Garcia, None; A. Gonzalez–Saiz, None; A. Morilla–Grasa, None; A. Enriquez de Salamanca, None; C. Garcia–Vazquez, None; J.M. Herreras, None; M. Calonge, None.
  • Footnotes
    Support  Avizor, Madrid, Spain
Investigative Ophthalmology & Visual Science May 2006, Vol.47, 107. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      G. Fuentes–Paez, M.J. Gonzalez–Garcia, A. Gonzalez–Saiz, A. Morilla–Grasa, A. Enriquez de Salamanca, C. Garcia–Vazquez, J.M. Herreras, M. Calonge; Evaluation of Clinical Tolerance to Soft Contact Lens (SCL) Care Systems . Invest. Ophthalmol. Vis. Sci. 2006;47(13):107.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : There are several soft contact lens (SCL) care systems in the market, with proved efficacy against microorganisms that achieves an adequate disinfection of the CL. However, the chemical composition of the care systems can cause adverse reactions in the ocular surface that can influence the tolerance of the CL. The purpose of this study is to evaluate and compare symptomatology and clinical response of SCL wearers using different care systems after 2 months of SCL use.

Methods: : 45 SCL wearers were randomly assigned to use either Ever Clean® –hydrogen peroxide–based system with Self Action®– (EC) or one of the next three care systems: ReNu Multiplus® multipurpose solution (RN), Opti–Free Express® multipurpose disinfecting solution (OF) or Oxysept Comfort® –hydrogen peroxide–based system– (OX) for 2–month periods with 1 week of washout. Subjects were fitted with FDA group IV SCL and new lenses were dispensed with each care regimen. Subjects were evaluated at baseline, 1 month (V1) and 2 months (V2) of SCL use. Clinical endpoints were: comfort with SCL, dry eye–related symptoms, visual acuity, contrast sensitivity, NIBUT, bulbar and limbal hyperemia, tarsal conjunctival reaction (redness and presence of tarsal papillae), corneal fluorescein staining and lissamine green conjunctival staining. Changes were statistically evaluated over time for each care system (Student’s t test) and among care systems (multiple comparison procedure of Scheffe).

Results: : Some care systems started to elicit symptoms and signs as soon as 1 month after (V1), always increasing at two months (V2). All care systems induced conjunctival hyperemia and some degree of ocular surface vital staining. NIBUT was only decreased with the use of multipurpose solution (RN, OF) and unaltered with the oxygen–based care systems. In general, peroxide–based systems (specially EC) behaved better than multipurpose solutions, specifically in NBUT, vital staining, and upper tarsal reaction.

Conclusions: : Some of the changes observed over time (2 months) may have been due to the presence of a contact lens, but some seemed to be care system–dependent. The use of some SCL care systems seemed to alter the ocular surface less than others. This could be due to a higher cleaning efficacy and/or a better tolerance.

Keywords: contact lens • cornea: tears/tear film/dry eye 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×